Evaluation of association between immune modulation and incidence of CMV reactivation in Sepsis-induced immunosuppression

Evaluation of association between immune modulation and incidence of CMV reactivation in Sepsis-induced immunosuppression

Bibliographic Details
Main Authors:	G. Lambe, F. Kapadia, C. Rodrigues, S. Khodaiji, D. Mansukhani, A. Shetty
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220314375

Similar Items

Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
by: Vanessa Wiening, et al.
Published: (2021-01-01)

Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
by: Ren-Qi Yao, et al.
Published: (2022-05-01)

Sepsis-Induced Immunosuppression in Neonates
by: Julie E. Hibbert, et al.
Published: (2018-11-01)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
by: Margaret A. McBride, et al.
Published: (2021-02-01)

Case report: CMV retinitis following local and systemic immunosuppression
by: Bryant A. Menke, et al.
Published: (2024-03-01)

Understanding sepsis-induced immunosuppression and organ dysfunctions: from immunosuppression to immunotherapy
by: Dablu Lal Gupta, et al.
Published: (2022-08-01)

CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases
by: Prem N. Patel, et al.
Published: (2023-08-01)

Resistant CMV infection in a transplant patient. Letermovir and withdrawal of immunosuppression
by: María Crucio López, et al.
Published: (2023-09-01)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
by: Monica Miele, et al.
Published: (2021-03-01)

Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree.
by: Katrin Schmoeckel, et al.
Published: (2018-01-01)

Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens
by: Ludwig Deml, PhD, et al.
Published: (2021-11-01)

In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV
by: Markus Benedikt Krueger, et al.
Published: (2024-04-01)

Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression
by: Alexis Garduno, et al.
Published: (2023-04-01)

Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression
by: Fei Pei, et al.
Published: (2022-12-01)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.
by: Maximilian C Aichelburg, et al.
Published: (2015-01-01)

Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
by: María Iglesias-Escudero, et al.
Published: (2018-01-01)

Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
by: Di Liu, et al.
Published: (2022-10-01)

Sever lower gastro-intestinal bleeding by CMV in a kidney transplant with low-dose immunosuppression
by: Antonio Ríos, et al.
Published: (2016-07-01)

Identification of qualitative characteristics of immunosuppression in sepsis based on immune-related genes and immune infiltration features
by: Ni Zeng, et al.
Published: (2024-04-01)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
by: Paul V. Lehmann, et al.
Published: (2012-04-01)

CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update
by: Xiao-Hua Luo, et al.
Published: (2021-10-01)

IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
by: Małgorzata Mizerska-Wasiak, et al.
Published: (2021-07-01)

Tissue-specific control of latent CMV reactivation by regulatory T cells.
by: Maha Almanan, et al.
Published: (2017-08-01)

Advances in the Study of Immunosuppressive Mechanisms in Sepsis
by: Fu X, et al.
Published: (2023-09-01)

Immunosuppression in sepsis and possibility of its correction
by: M. V. Kiselevskii, et al.
Published: (2018-10-01)

Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
by: Seung Mo Jin, et al.
Published: (2021-10-01)

Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD
by: Davide Piloni, et al.
Published: (2022-11-01)

Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options
by: Fei Pei, et al.
Published: (2024-03-01)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
by: Yujun Xu, et al.
Published: (2019-12-01)

Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression
by: Chao Ren, et al.
Published: (2017-12-01)

Rapid Detection of <i>Plasmodium vivax</i> by the Hematology Analyzer for Population Screening
by: Shanaz Khodaiji, et al.
Published: (2023-11-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
by: Hyeyoung Lee, et al.
Published: (2017-01-01)

Aging and CMV discordance are associated with increased immune diversity between monozygotic twins
by: Zheng Yan, et al.
Published: (2021-01-01)

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
by: Katya Prakash, et al.
Published: (2021-05-01)

Correction to: Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
by: Yaxian Xue, et al.
Published: (2022-01-01)

T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside
by: Jian-Feng Xie, et al.
Published: (2017-01-01)

Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia
by: Marwan Bouras, et al.
Published: (2018-11-01)

Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression
by: Yanwei Cheng, et al.
Published: (2018-11-01)

P1334: THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: A. Dmitrova, et al.
Published: (2022-06-01)

Incidence and differentiation of Cucumber mosaic virus (CMV) isolates in Peninsular Malaysia
by: Saad, Norsazilawati
Published: (2012)